PREVIOUS PRESS RELEASES
TheraVet extends the use of BIOCERA-VET to new curative approach of osteosarcoma in dogs
TheraVet announces its 2021 financial calendar
TheraVet: Successful IPO on Euronext Growth® Paris and Brussels
June 11, 2021
TheraVet (ISIN: BE0974387194 - ticker: ALVET), a biotechnology company specialising in osteoarticular treatments for animals, is today announcing the results of its successful initial public offering on Euronext Growth® Paris and Brussels. ...
To view TheraVet's opening bell ceremony, click here.
TheraVet: Initial Public Offering on Euronext Growth® Brussels and Paris
TheraVet announces the commercial launch of BIOCERA-VET